Recent Updates
Recently added Catalysts
EVO Negative Sentiment

Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook

Key Takeaway: Evotec SE has released preliminary financial results for the second quarter and first half of 2026, indicating a significant drop in expected revenues and EBITDA. The company now anticipates full-year revenues between €570 million and €610 million, down from previous estimates. Adjusted EBITDA is also expected to be negative, reflecting challenges in the current financial landscape.
Price reaction · baseline $2.33 (2026-07-13T19:42:00.000Z) · hit during market hours · clean, no other EVO news in the window
day 0 close · peak
+4.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Preliminary revenues indicate a significant amount of approximately €300.1 million.
  • Liquidity remains strong at approximately €465.6 million.

CONCERNS & RISKS

  • Adjusted Group EBITDA is projected to be significantly negative at approximately -€42.7 million.
  • Full-year revenue guidance has been lowered from €700-780 million to €570-610 million.

Full Press Release Details

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014

HAMBURG, Germany,July 13, 2026/PRNewswire/ -- Evotec SE (NASDAQ:EVO) (Frankfurt Prime Standard: EVT) today announced preliminary unaudited financial results for the second quarter and first half of 2026 and updated its full-year 2026 outlook. Full financial results for the second quarter and first half of 2026 will be published on August 13, 2026, as scheduled.
Based on preliminary figures, Evotec expects Group revenues for the first half of 2026 of approximately €300.1 million and adjusted Group EBITDA of approximately -€42.7 million. As of June 30, 2026, liquidity is expected to amount to approximately €465.6 million.
Reflecting these factors, Evotec now expects full-year 2026 Group revenues of approximately €570 to 610 million (€595 to 635 million CER) and adjusted Group EBITDA of approximately -€70 to -105 million (-€60 to -90 million CER). This compares with previous guidance of €700 to 780 million (€730 to 810 million CER) for Group revenues and €0 to 40 million (€10 to 50 million CER) for adjusted Group EBITDA.
Contact: Dr. Sarah Fakih, EVP Head of Global Communications and Investor Relations, Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Phone: +49(0)151 7068 8784 (m),[email protected]

Frequently Asked Questions

What were Evotec's preliminary revenues for H1 2026?

Evotec's preliminary revenues for the first half of 2026 are approximately €300.1 million.

What is the updated full-year revenue outlook for Evotec?

Evotec now expects full-year 2026 revenues between €570 million and €610 million.

What is the projected adjusted EBITDA for Evotec in 2026?

The adjusted Group EBITDA for Evotec is projected to be between -€70 million and -€105 million.

When will Evotec publish full financial results?

Evotec will publish full financial results for Q2 and H1 2026 on August 13, 2026.

Last updated: Jul 13, 2026